Short-term exposure of umbilical cord blood CD34⁺ cells to granulocyte–macrophage colony-stimulating factor early in culture improves ex vivo expansion of neutrophils

References

• Ziglam HM, Gelly K, Olver W. A survey of the management of neutropenic fever in oncology units in the UK. Int J Antimicrob Agents. 2007;29:430–3.
   PubMed Web of Science ®Google Scholar
• Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apher. 1996;11:1–9.
   PubMedGoogle Scholar
• Ofran Y, Avivi I, Oliven A, Oren I, Zuckerman T, Bonstein L, . Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions. Vox Sang. 2007;93:363–9.
   PubMed Web of Science ®Google Scholar
• Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, . Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood. 2000;95:3302–9.
   PubMed Web of Science ®Google Scholar
• Kerr JP, Liakopolou E, Brown J, Cornish JM, Fleming D, Massey E, . The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol. 2003;123: 114–8.
   PubMed Web of Science ®Google Scholar
• Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, . Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage. Transfusion. 2006;46:14–23.
   PubMed Web of Science ®Google Scholar
• Vamvakas EC, Pineda AA. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apher. 1997;12:74–81.
   PubMed Web of Science ®Google Scholar
• Haylock DN, To LB, Dowse TL, Juttner CA, Simmons PJ. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood. 1992;80:1405–12.
   PubMed Web of Science ®Google Scholar
• Prince HM, Simmons PJ, Whitty G, Wall DP, Barber L, Toner GC, . Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol. 2004;126:536–45.
   PubMed Web of Science ®Google Scholar
• Reiffers J, Cailliot C, Dazey B, Attal M, Caraux J, Boiron JM. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet. 1999;354:1092–3.
   PubMedGoogle Scholar
• McNiece I, Jones R, Cagnoni P, Bearman S, Nieto Y, Shpall EJ. Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. Hematol Cell Ther. 1999; 41:82–6.
   PubMedGoogle Scholar
• Paquette RL, Dergham ST, Karpf E, Wang HJ, Slamon DJ, Souza L, . Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood. 2000;96:2385–90.
   PubMed Web of Science ®Google Scholar
• McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, . Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood. 2000;96: 3001–7.
   PubMed Web of Science ®Google Scholar
• Reichle A, Zaiss M, Rothe G, Schmitz G, Andreesen R. Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells. Bone Marrow Transplant. 2003;32:299–305.
   PubMedGoogle Scholar
• Timmins NE, Palfreyman E, Marturana F, Dietmair S, Luikenga S, Lopez G, . Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells. Biotechnol Bioeng. 2009;104:832–40.
   PubMedGoogle Scholar
• Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, . Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant. 2006;12: 1020–30.
   PubMed Web of Science ®Google Scholar
• Madlambayan GJ, Rogers I, Kirouac DC, Yamanaka N, Mazurier F, Doedens M, . Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol. 2005;33:1229–39.
   PubMedGoogle Scholar
• Haylock DN, Horsfall MJ, Dowse TL, Ramshaw HS, Niutta S, Protopsaltis S, . Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 LIGAND. Blood. 1997;90:2260–72.
   PubMed Web of Science ®Google Scholar
• Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, . Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89:2644–53.
   PubMed Web of Science ®Google Scholar
• Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34(+)Thy-1(+)Lin(−) cells with preserved ability to engraft SCID-hu bone. Blood. 1998;91: 1206–15.
   PubMed Web of Science ®Google Scholar
• Piacibello W, Sanavio F, Severino A, Dane A, Gammaitoni L, Fagioli F, . Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood. 1999;93: 3736–49.
   PubMed Web of Science ®Google Scholar
• Qiu LG, Meagher R, Welhausen S, Heye M, Brown R, Herzig RH. Ex vivo expansion of CD34(+) umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. J Hematother Stem Cell Res. 1999;8: 609–18.
   PubMedGoogle Scholar
• Kusadasi N, van Soest PL, Mayen AE, Koevoet JLM, Ploemacher RE. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia. 2000;14:1944–53.
   PubMed Web of Science ®Google Scholar
• Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, . Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science. 1997;276:1696–9.
   PubMed Web of Science ®Google Scholar
• Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, . Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant. 2006;12: 1020–30.
   PubMed Web of Science ®Google Scholar
• Fung YL, Pitcher LA, Willett JE, Reed C, Mison L, Bux J, . Alloimmune neonatal neutropenia linked to anti-HNA-4a. Transfus Med. 2003;13:49–52.
   PubMedGoogle Scholar
• Shah AJ, Smogorzewska EM, Hannum C, Crooks GM. FLT3 ligand (FL) is a potent inducer of proliferation of highly quiescent human bone marrow CD34+CD38− cells. Blood. 1995;86:1677.
   Google Scholar
• Shah AJ, Smogorzewska EM, Hannum C, Crooks GM. Flt3 ligand induces proliferation of quiescent human bone marrow CD34(+)CD38(−) cells and maintains progenitor cells in vitro. Blood. 1996;87:3563–70.
   PubMed Web of Science ®Google Scholar
• Madlambayan GJ, Rogers I, Kirouac DC, Yamanaka N, Mazurier F, Doedens M, . Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol. 2005;33:1229–39.
   PubMedGoogle Scholar
• Timmins NE, Nielsen LK. Blood cell manufacture: current methods and future challenges. Trends Biotechnol. 2009;27: 415–22.
   PubMedGoogle Scholar
• Bennaceur-Griscelli A, Pondarre C, Schiavon V, Vainchenker W, Coulombel L. Stromal cells retard the differentiation of CD34(+) CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic history. Blood. 2001;97:435–41.
   PubMed Web of Science ®Google Scholar
• Borge OJ, Ramsfjell V, Cui L, Jacobsen SEW. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34(+)CD38(−) bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood. 1997;90:2282–92.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood. 1996;88:429–36.
   PubMed Web of Science ®Google Scholar
• Piacibello W, Sanavio F, Garetto L, Severino A, Dane A, Gammaitoni L, . Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia. 1998;12:718–27.
   PubMed Web of Science ®Google Scholar
• Gothot A, van der Loo JCM, Clapp DW, Srour EF. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic severe combined immune-deficient mice. Blood. 1998;92:2641–9.
   PubMed Web of Science ®Google Scholar
• Schiedlmeier B, Kuhlcke K, Eckert HG, Baum C, Zeller WJ, Fruehauf S. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood. 2000;95: 1237–48.
   PubMed Web of Science ®Google Scholar
• Murray LJ, Young JC, Osborne LJ, Luens KM, Scollay R, Hill BL. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34(+) cells and recruit primitive CD34(+)Thy-1(+) cells into rapid division. Exp Hematol. 1999;27:1019–28.
   PubMed Web of Science ®Google Scholar
• Lill MC, Lynch M, Fraser JK, Chung GY, Schiller G, Glaspy JA, . Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex-vivo expansion system. Stem Cells. 1994;12:626–37.
   PubMed Web of Science ®Google Scholar
• Scheding S, Meister B, Buhring HJ, Baum CM, McKearn JP, Bock T, . Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells. Exp Hematol. 2000;28:460–70.
   PubMedGoogle Scholar
• Grotendorst GR, Smale G, Pencev D. Production of transforming growth-factor beta by human peripheral-blood monocytes and neutrophils. J Cell Physiol. 1989;140:396–402.
   PubMed Web of Science ®Google Scholar
• Mayani H, Little MT, Dragowska W, Thornbury G, Lansdorp PM. Differential-effects of the hematopoietic inhibitors MIP-1-alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34(+) cells purified from cord-blood and fetal liver. Exp Hematol. 1995; 23:422–7.
   PubMed Web of Science ®Google Scholar
• Cashman JD, Eaves CJ, Sarris AH, Eaves AC. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures. Blood. 1998;92:2338–44.
   PubMed Web of Science ®Google Scholar
• Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, . IFN-γ negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol. 2005;174: 752–7.
   PubMed Web of Science ®Google Scholar
• Huang CH, Chen PM, Lu TC, Kung WM, Chiou TJ, Yang MH, . Purified recombinant TAT-HOXB4 expands CD34+ umbilical cord blood and peripheral blood progenitor cells ex vivo. Tissue Eng Part C Methods. 2009;16(3):487-496.
   Google Scholar
• Amsellem S, Pflumio F, Bardinet D, Izac B, Charneau P, Romeo PH, . Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med. 2003;9:1423–7.
   PubMed Web of Science ®Google Scholar
• Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 2010;16:232–6.
   PubMed Web of Science ®Google Scholar
• Haylock DN, To LB, Dowse TL, Juttner CA, Simmons PJ. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood. 1992;80:1405–12.
   PubMed Web of Science ®Google Scholar
• Makino S, Haylock DN, Dowse T, Trimboli S, Niutta S, To LB, . Ex vivo culture of peripheral blood CD34+ cells: effects of hematopoietic growth factors on production of neutrophilic precursors. J Hematother. 1997;6:475–89.
   PubMedGoogle Scholar
• Lazzari L, Lucchi S, Rebulla P, Porretti L, Puglisi G, Lecchi L, . Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br J Haematol. 2001;112:397–404.
   PubMed Web of Science ®Google Scholar
• Kohler T, Plettig R, Wetzstein W, Schaffer B, Ordemann R, Nagels HO, . Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells. 1999;17:19–24.
   PubMed Web of Science ®Google Scholar
• Capmany G, Querol S, Cancelas J, Garcia J. Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells. Haematologica. 1999;84:675–82.
   PubMedGoogle Scholar
• Brandt J, Srour EF, van Besien K, Briddell RA, Hoffman R. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest. 1990;86:932–41.
   PubMed Web of Science ®Google Scholar
• Flores-Guzman P, Gutierrez-Rodriguez M, Mayani H. In vitro proliferation, expansion, and differentiation of a CD34+ cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res. 2002;33:107–14.
   PubMed Web of Science ®Google Scholar
• Yao C-L, Chu IM, Hsieh T-B, Hwang S-M. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol. 2004;32:720–7.
   PubMed Web of Science ®Google Scholar
• Hino M, Suzuki K, Yamane T, Sakai N, Kubota H, Koh KR, . Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells. Br J Haematol. 2000;109:314–21.
   PubMedGoogle Scholar
• Goto T, Kino T, Hatanaka H, Nishiyama M, Okuhara M, Kohsaka M, . Discovery of Fk-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc. 1987;19:4–8.
   PubMed Web of Science ®Google Scholar
• Koenig JM, Matharoo N, Stegner JJ, Schowengerdt JKO. Tacrolimus: in vitro effects on myelopoiesis, apoptosis, and CD11b expression. J Heart Lung Transplant. 2005;24:1332–6.
   PubMedGoogle Scholar
• Hirao A, Kawano Y, Takaue Y. Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis. Blood. 1993;81:1179–83.
   PubMedGoogle Scholar
• LaIuppa JA, Papoutsakis ET, Miller WM. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol. 1998;26:835–43.
   PubMed Web of Science ®Google Scholar
• Hevehan DL, Wenning LA, Papoutsakis ET, Miller WM. A dynamic model of ex vivo granulopoiesis: effects of oxygen tension, pH, and IL-3. Exp Hematol. 2000;28(9):1016–28.
   PubMedGoogle Scholar
• Hevehan DL, Papoutsakis ET, Miller WM. Physiologically significant effects of pH and oxygen tension on granulopoiesis. Exp Hemat. 2000;28:267–75.
   PubMed Web of Science ®Google Scholar
• Koller MR, Bender JG, Papoutsakis ET, Miller WM. Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitors. Blood. 1992;80:403–11.
   PubMed Web of Science ®Google Scholar
• Bug G, Gul H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X, . Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res. 2005;65:2537–41.
   PubMed Web of Science ®Google Scholar
• Seet L-F, Teng E, Lai Y-S, Laning J, Kraus M, Wnendt S, . Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions. Eur J Haematol. 2009;82: 124–32.
   PubMedGoogle Scholar